Leukemia Clinical Trials in Los Angeles

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
F
Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Not yet recruiting
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • +33 more
  • Informational Intervention
  • +4 more
  • Los Angeles, California
  • +4 more
2022-04-04
Apr 4, 2022
S
A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma
Recruiting
  • Leukemia
  • Lymphoma
  • SCRI-CAR22v2
  • Los Angeles, California
  • +4 more
2022-04-02
Apr 2, 2022
S
A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia
Recruiting
  • Leukemia
  • Lymphoma
  • Patient-derived CD19- and CD22 specific CAR
  • Los Angeles, California
  • +4 more
2022-04-02
Apr 2, 2022
C
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Active, not recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • +3 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +3 more
  • Birmingham, Alabama
  • +42 more
2022-03-22
Mar 22, 2022
C
A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis
Recruiting
  • Myelofibrosis
  • +13 more
  • Phoenix, Arizona
  • +54 more
2022-03-04
Mar 4, 2022
P
A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients
Active, not recruiting
  • Leukemia
  • +2 more
  • inotuzumab ozogamicin-dose level 2
  • Inotuzumab ozogamicin-dose level 1
  • Los Angeles, California
  • +45 more
2022-03-09
Mar 9, 2022
C
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
  • Acute Lymphoblastic Leukemia
  • +13 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Birmingham, Alabama
  • +68 more
2022-03-03
Mar 3, 2022
I
A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemia
Recruiting
  • Leukemia
  • Birmingham, Alabama
  • +107 more
2022-02-22
Feb 22, 2022
C
The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors
Recruiting
  • Cancer
  • +21 more
  • Virtual group based physical activity (BurnAlong) and Social Media Discussion Board
  • Los Angeles, California
    Cedars-Sinai Medical Center
2022-02-07
Feb 7, 2022
S
CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma
Active, not recruiting
  • Leukemia
  • Lymphoma
  • SCRI-huCAR19v1
  • SCRI-huCAR19v2
  • Los Angeles, California
  • +1 more
2022-02-15
Feb 15, 2022
G
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Recruiting
  • Cancer
  • +22 more
  • Elly Mobile Phone Application
  • Los Angeles, California
    Cedars Sinai Medical Center
2021-12-07
Dec 7, 2021
B
An Investigational Immuno-therapy Study of Ulocuplumab in Combination With Low Dose Cytarabine in Patients With Newly Diagnosed Acute Myeloid Leukemia - 2019
Terminated
Has Results
  • Leukemia
  • Los Angeles, California
  • +37 more
2021-08-18
Aug 18, 2021
S
Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia - 2002
Completed
  • Leukemia
  • Duarte, California
  • +19 more
2021-06-07
Jun 7, 2021
B
Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell Transplantation - 2003
Terminated
  • Leukemia
  • +2 more
  • Los Angeles, California
  • +12 more
2021-05-03
May 3, 2021
C
Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia - 2020
Completed
Has Results
  • Leukemia
  • Birmingham, Alabama
  • +197 more
2021-03-22
Mar 22, 2021
F
Survivorship Care in Reducing Symptoms in Young Adult Cancer Survivors - 2019
Completed
  • Breast Carcinoma
  • +12 more
  • Management of Therapy Complications
  • +3 more
  • Los Angeles, California
  • +5 more
2020-10-08
Oct 8, 2020
C
Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes - 2005
Terminated
  • Leukemia
  • +2 more
  • arsenic trioxide
  • Tucson, Arizona
  • +7 more
2020-10-02
Oct 2, 2020
J
BMS-354825 in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Is Resistant to Imatinib Mesylate - 2006
Completed
  • Leukemia
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
2020-07-30
Jul 30, 2020
J
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter - 2000
Completed
  • Cervical Cancer
  • +8 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
2020-07-30
Jul 30, 2020
J
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Completed
  • Anemia
  • +6 more
  • darbepoetin alfa
  • epoetin alfa
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center, UCLA
2020-07-30
Jul 30, 2020
J
Azacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic Syndromes
Terminated
  • Leukemia
  • Myelodysplastic Syndromes
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
2020-07-29
Jul 29, 2020
E
A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene - 2016
Completed
  • Leukemia
  • +3 more
  • Los Angeles, California
  • +8 more
2020-05-07
May 7, 2020
A
Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer - 2007
Withdrawn
  • Leukemia
  • +4 more
  • alemtuzumab
  • +6 more
  • La Jolla, California
  • +23 more
2019-11-25
Nov 25, 2019
S
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Recruiting
  • All Diagnosed Health Conditions
  • +60 more
    • Los Angeles, California
      Sanguine Biosciences
    2019-10-04
    Oct 4, 2019
    S
    Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML - 2015
    Terminated
    Has Results
    • Leukemia, Myeloid
    • +2 more
    • Allogeneic HSCT
    • +6 more
    • Hayward, California
    • +4 more
    2019-09-11
    Sep 11, 2019